Ashforth E I L, Palmer J L, Bye A, Bedding A (1994) The pharmacokinetics of ondansetron after intravenous injection in healthy volunteers phenotyped as poor or extensive metabolisers of debrisoquine. Br J Clin Pharmacol37: 389–391
2.
Dixon C M, Colthup P V, Serabjit-Singh C J et al. (1995) Multiple forms of cytochrome P450 are involved in the metabolism of ondansetron in humans. Drug Metab Dispos23: 1225–1230
3.
Stanford B J, Stanford S C (1999) Postoperative delirium indicating an adverse drug interaction involving the selective serotonin reuptake inhibitor, paroxetine?J Psycopharmacol13: 313–317
